Table 2.
Intraoperative, postoperative variables and study outcomes.
Non-transfusion group (n = 22) | Transfusion group (n = 31) | P | |
---|---|---|---|
Intraoperative variables | |||
Operation time (min) | 46 (33.0–60.4) | 58 (44.0–72.5) | 0.067 |
Crystalloid (mL) | 2000.0 (1800.0–2300.0) | 1950.0 (1462.5–2375.0) | 0.850 |
Colloid use | 4 (18.1) | 11 (32.3) | 0.172 |
Urine output (mL) | 50 (45.0–90.0) | 60 (40.0–100.0) | 0.926 |
Estimated blood loss (mL) | 1000.0 (1000.0–1100.0) | 1500.0 (1000.0–2375.0) | 0.007 |
Transfusion | |||
RBC, units | 0 (0.0–0.0) | 2.4 (2.0–5.8) | <0.001 |
Massive transfusion (≥10 units) | 0 (0.0) | 4 (12.9) | 0.132 |
FFP | 0 (0.0) | 11 (35.5) | 0.001 |
PC | 0 (0.0) | 2 (6.5) | 0.505 |
Postoperative variables | |||
Analgesic use | 16 (72.7%) | 19 (61.3%) | 0.391 |
Study outcomes | |||
Postoperative NLR | 6.8 (5.0–9.4) | 12.2 (8.0–14.4) | <0.001 |
Postoperative PLR | 117.4 (90.4–161.3) | 108.0 (90.4–172.9) | 0.885 |
Postoperative RDW | 13.9 (13.2–14.3) | 14.6 (13.9–14.9) | 0.002 |
Data are expressed as mean (standard deviation), number (%), or median (interquartile range). RBC, red blood cell; FFP, fresh frozen plasma; PC, platelet concentrates; NLR, neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte ratio; RDW, red cell distribution width.